Evidence map›Paper›PMID 41188248›Full record

ArticleNature communications2025

Streamlined construction of boron-stereogenic BODIPY library for near-infrared bioimaging.

Jiayi Zhao, Li-Qing Ren, Deren Lan, Baoquan Zhan, Jinyuan Zhang, Jing Mu, Chuan He

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Cobalt-Catalyzed Asymmetric Construction of Boron Stereocenters With C-N Axial Chirality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jiayi Zhao *Shenzhen Grubbs Institute and Department of Chemistry, Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID http://orcid.org/0009-0004-0834-1755
Li-Qing Ren *Shenzhen Grubbs Institute and Department of Chemistry, Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID http://orcid.org/0009-0000-3878-3117
Deren Lan *Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Baoquan ZhanShenzhen Grubbs Institute and Department of Chemistry, Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen, Guangdong, China.ORCID http://orcid.org/0000-0002-6572-9922
Jinyuan ZhangDepartment of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Jing MuInstitute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, China. jing.mu@pkuszh.com.ORCID http://orcid.org/0000-0002-7508-1461
Chuan HeShenzhen Grubbs Institute and Department of Chemistry, Shenzhen Key Laboratory of Small Molecule Drug Discovery and Synthesis, Guangdong Provincial Key Laboratory of Catalysis, Southern University of Science and Technology, Shenzhen, Guangdong, China. hec@sustech.edu.cn.ORCID http://orcid.org/0000-0002-9983-7526

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22271134
6 · The paper itself

Abstract

Chirality is fundamental to molecular recognition, critically influencing pharmaceutical interactions, biomolecular sensing, and chiroptical device performance. While chiroptical luminophores hold transformative potential for optoelectronic innovation and precision bioimaging, their rational engineering remains constrained by synthetic limitations. Here, we report a streamlined and programmable asymmetric synthesis platform enabling systematic construction of boron-stereogenic boron dipyrromethene (BODIPYs) with near-infrared (NIR) chiroptical activity. This approach enables precise functionalization of prochiral BODIPYs via catalytic enantioselective cross-coupling, affording increased π-conjugated dyes with excellent enantiomeric excess and tunable photophysical properties. Further study demonstrates that molecular chirality plays a critical role in cellular recognition, as our chiral BODIPY dyes exhibit enantioselective uptake and distinct subcellular localization in cells. When formulated as nanoparticles, these dyes enable high-resolution NIR-II vascular imaging. This work not only establishes boron-centered stereogenicity as a design paradigm for advanced chiroptical bioimaging probes but also unveils dimensions in chiral organoboron chemistry with implications spanning from targeted therapeutics to chiral photonics.

Indexed as

BoronBoron CompoundsFluorescent DyesHumansNanoparticlesSpectroscopy, Near-InfraredStereoisomerism4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoronBoron CompoundsFluorescent Dyes

Identifiers

PMID41188248
PMCPMC12586572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.